ARK Genomic Revolution Multi-Sector ETF (ARKG)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in ARK Genomic Revolution Multi-Sector ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

ARK Genomic Revolution Multi-Sector ETF (ARKG) has returned -8.80% so far this year and 27.26% over the past 12 months. Over the last ten years, ARKG has returned 4.69% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Oct 31, 2014, ARKG's average daily return is +0.04%, while the average monthly return is +0.78%. At this rate, your investment would double in approximately 7.4 years.

Historically, 48% of months were positive and 52% were negative. The best month was Apr 2020 with a return of +30.1%, while the worst month was Apr 2022 at -26.0%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 8 months.

On a daily basis, ARKG closed higher 52% of trading days. The best single day was Apr 9, 2025 with a return of +12.1%, while the worst single day was Mar 16, 2020 at -13.8%.

ARK Genomic Revolution Multi-Sector ETF has an annualized alpha of -5.63%, beta of 1.39, and R² of 0.39 versus S&P 500 Index. Calculated based on daily prices since November 03, 2014.

• This ETF participated in 166.93% of S&P 500 Index downside but only 144.92% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.39 means the benchmark explains less than half of this ETF's behavior — treat beta with caution or consider switching to a more representative benchmark.

ARKG has an expense ratio of 0.75%, placing it in the medium range.

ARKG ranks 32 for risk / return — below 32% of ETFs on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and compare them to a chosen benchmark (S&P 500 Index).

ARK Genomic Revolution Multi-Sector ETF provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.

The table displays the monthly dividend distributions for ARK Genomic Revolution Multi-Sector ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the ARK Genomic Revolution Multi-Sector ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ARK Genomic Revolution Multi-Sector ETF was 83.59%, occurring on Apr 8, 2025. The portfolio has not yet recovered.

The current ARK Genomic Revolution Multi-Sector ETF drawdown is 76.36%.

The chart below shows the rolling one-month volatility.